Table 1.
Patients' demographics.
| Variable | Total | Tramadol | Celecoxib | P |
|---|---|---|---|---|
| (n = 73) | (n = 36) | (n = 37) | ||
| Age (years) | 70.9 ± 12.3 | 71 ± 11.5 | 70.4 ± 13 | 0.37 |
| Male/female | 23/50 | 12/24 | 11/26 | 0.74 |
| Pain duration (months) | 50 ± 54.5 | 49.6 ± 58.3 | 50.7 ± 52.4 | 0.47 |
| Apathy Scale (points) | 15.8 ± 6.6 | 16.2 ± 5.3 | 15.5 ± 6.1 | 0.47 |
| NRS | 7.1 ± 1.9 | 7.5 ± 1.4 | 6.9 ± 2.1 | 0.08 |
| RDQ (points) | 12.2 ± 5.9 | 12.3 ± 5.7 | 12.1 ± 5.4 | 0.92 |
| PDAS (points) | 29.8 ± 15.3 | 31.7 ± 15.5 | 28.6 ± 15.3 | 0.56 |
| HADS anxiety (points) | 7.8 ± 4.6 | 8.1 ± 4.6 | 7.6 ± 4.1 | 0.63 |
| HADS depression (points) | 7.2 ± 4.0 | 7.2 ± 3.8 | 7.1 ± 3.8 | 0.89 |
| PCS (points) | 35.1 ± 12.9 | 35.1 ± 12 | 35.1 ± 12.1 | 0.99 |
NRS: numerical rating scale; RDQ: Rolland-Morris Disability Questionnaire; PDAS: Pain Disability Assessment Scale; HADS: Hospital Anxiety and Depression Scale; PCS: Pain Catastrophizing Scale; data presented as mean ± SD unless otherwise indicated.